Global Autism Screening Tool Validation Study Pilot: Version 1
Research type
Research Study
Full title
\nGlobal Autism Screening Tool Validation Study Pilot –\nCognitive Testing and Validation in Liverpool \n
IRAS ID
258870
Contact name
Melissa Gladstone
Contact email
Duration of Study in the UK
0 years, 5 months, 1 days
Research summary
Autism Spectrum Disorder (ASD) is a developmental disorder affecting children globally where children often have\nproblems with social communication and interaction, repetitive and restricted behaviour. Questionnaire style ’tools’\nhave been developed, which can help with diagnosis, although these tend to be developed for use in Western\ncountries and their use is not transferable globally. The development of a tool for global use will allow improved\ndiagnosis in diverse settings as well as enabling researchers to understand the presentation and diagnosis of the\ncondition on a global scale.\nThis project is a pilot study to pilot validation methods for a newly developed screening tool (created with a team of\nresearchers from the World Bank) for identifying children with ASD, that has been developed for use in different\npopulations around the world.\nThe study will be in a single centre (Alder Hey Children’s Hospital) and will look at testing appropriate methods with 20\nparticipants who have a child on the Autism Pathway at Alder Hey Hospital. Two questionnaire based interviews will\nidentify the following; 1) How well the questions in the ASD tool work with their target audience; which is parents of\nchildren with suspected ASD (the cognitive testing interview) and 2) How effectively the tool identifies children with ASD\n(the screening tool validation phase). The results from the tool validation will also use the child’s medical records\nand ASD assessment outcome from the clinic to assess tool validity.\nThe study is a pilot study for two Third year medical students to contribute to their Research project’s that contribute\ntowards their medical degrees and forms a sub-study to inform a future international study (which will include sites in\nKenya, South Africa and UK) that has only recently received confirmation of funding by Autism Speaks.\n
REC name
West of Scotland REC 3
REC reference
19/WS/0010
Date of REC Opinion
21 Feb 2019
REC opinion
Further Information Favourable Opinion